ST Pharm (237690.KQ) Earnings Analysis
ST Pharm (237690.KQ) has no confirmed upcoming earnings date. It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E 35.38.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 237690.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 237690.KQ. This page updates as the calendar is published.
237690.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-27 | 725 KRW | n/a | n/a | n/a |
| 2026-02-09 | 1,489.25 KRW | n/a | n/a | n/a |
| 2025-10-29 | 849.01 KRW | n/a | n/a | n/a |
| 2025-02-10 | 637.78 KRW | n/a | n/a | n/a |
| 2024-11-01 | 545.08 KRW | n/a | n/a | n/a |
| 2024-07-25 | 51.93 KRW | 228.54 KRW | -77.3% | Miss |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
237690.KQ valuation and analyst view
| Trailing P/E | 35.38 |
|---|---|
| Trailing EPS | 3,322.13 KRW |
| Price / book | 4.01 |
| Dividend yield | 0.42% |
| Market cap | 2354.74B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is ST Pharm (237690.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 237690.KQ. This page updates as the calendar is published.
Did 237690.KQ beat earnings last quarter?
Consensus estimate data was not available for 237690.KQ's 2026-04-27 report.
What is 237690.KQ's earnings track record?
Over the last 1 reported quarters with consensus data, 237690.KQ beat estimates 0 times (0%).
What is 237690.KQ's current P/E ratio and EPS?
237690.KQ trades at a trailing P/E of 35.38 on trailing EPS of 3322.133609279492 KRW.
What do analysts rate 237690.KQ?
237690.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.